Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum AbbVie Inc. ABBV

Alternate Symbol(s):  ABBV.24B | ABBV.28B | ABBV.29 | ABBV.21C | ABBV.23B

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

you guy's still selling in russia

you know about the peolpe they are slaughtering and killing  rate and reply

ONE DRUG PILL WIPES OUT COVID 19!

India's Ivermectin Blackout - Part V: The Secret Revealed ...   Sep 27, 2021 · By September 12, 2021, Livemint reported that 34 districts were declared COVID-free...read more

Join Novo Resources (TSX:NVO) AGM 2022 | TODAY @ 4PM PST/7PM EST

Recognizing the important opportunity that an annual meeting provides shareholders to both hear from, and communicate with, management, a presentation and virtual question and answer period will be organized immediately subsequent to the Meeting, details of which will be announced in the near future. ...read more

what was the big drop ?? saw no news

what was the big drop ?? saw no news  rate and reply

Multiple Sclerosis Therapies Market Industry Growth 2026

According to IMARC Group’s latest report, titled “Multiple Sclerosis Therapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, The global multiple sclerosis...read more